Mucosal Bacterial Immunotherapy With MV130 Highly Reduces the Need of Tonsillectomy in Adults With Recurrent Tonsillitis
Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2019.1581537
Full Text
Open PDFAbstract
Available in full text
Date
April 17, 2019
Authors
Publisher
Informa UK Limited